Clik here to view.
Boston Scientific launches Promus Premier stent in Europe
Boston Scientific's Promus Premier drug-eluting stent wins CE Mark approval in the European Union.Boston Scientific (NYSE:BSX) said it plan to immediately launch its Promus Premier drug-eluting stent...
View ArticleClik here to view.
UPDATE: OrbusNeich claims European stent patent win over Boston Scientific
OrbusNeich claims a win in a European patent decision over Boston Scientific in their ongoing war over coronary stent technology.UPDATED Feb. 13, 2012 with comment from Boston Scientific.OrbusNeich...
View ArticleClik here to view.
Medical device tax will cost Boston Scientific $75M this year, CEO says
Boston Scientific CEO Michael Mahoney tells investors that the new 2.3% medical device sales tax will cost the company about $75 million in 2013.Medtech giant Boston Scientific (NYSE:BSX) estimates...
View ArticleClik here to view.
Vatican unveils outgoing Pope Benedict's secret pacemaker
Vatican officials unveil that outgoing Pope Benedict has had a pacemaker for years and that he recently underwent a routine battery replacement.Vatican officials revealed today that Pope Benedict has...
View ArticleClik here to view.
FDA slaps highest risk label on St. Jude Medical's Amplatzer TorqVue FX recall
St. Jude Medical recalls its Amplatzer TorqVue FX delivery system over concerns about fractures in the core wire.Corrected February 13, 2013, at 12:00 p.m. to clarify that the recalled component is...
View ArticleClik here to view.
New U.S. medical device tax on manufacturers and importers
By Stewart Eisenhart, Emergo GroupMany clients ask us about the new US Medical Device Excise Tax (MDET), so we wanted to provide a brief overview of the tax, which products it impacts and when payments...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for February 12, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of...
View ArticleClik here to view.
Hip implant costs are a medical mystery, study says | MassDevice.com On Call
A Washington University study on healthcare costs found that even hospitals have trouble figuring out how much a hip replacement costs.MASSDEVICE ON CALL — A Washington University project intended to...
View ArticleClik here to view.
The exodus begins
Westby G. Fisher, MD, FACC is a board certified internist, cardiologist, and cardiac electrophysiologist practicing at NorthShore University HealthSystem in Evanston, IL, USA and is a Clinical...
View ArticleClik here to view.
Medtronic brings MRI-friendly pacemaker to the U.S.
Medical device giant Medtronic lands FDA approval for its MRI-friendly Advisa pacemaker system.Medical device giant Medtronic (NYSE:MDT) won FDA approval for its Advisa DR MRI SureScan pacing system,...
View ArticleClik here to view.
Invacare ekes out 2012 profit, despite 'most challenging year'
Invacare manages a swing to 2012 black despite what CEO Gerald Blouch called 1 of "the most challenging" in the company's history.Invacare (NYSE:IVC) weathered what CEO Gerald Blouch called "1 of the...
View ArticleClik here to view.
Device makers respond to the State of the Union with renewed calls for device...
Medical device respond to President Barack Obama's State of the Union address, saying the call for strengthening the economy is incompatible with the medical device tax contained in the President's...
View ArticleClik here to view.
Value cases for clinical documentation improvement
Dr. John Halamka, Chief Information Officer for Beth Israel Deaconess Medical Center, records his experiences with infrastructure, applications, policies, management and governance.By John D. Halamka,...
View ArticleClik here to view.
Report: Healthcare hacks "likely to increase in frequency" in coming years
Malicious hackers are likely to target healthcare databases and patient medical records with increasing frequency in coming years, according to technology security auditing firm Redspin.Malicious...
View ArticleClik here to view.
Boston Scientific CFO: 'The portfolio is there. Now it's all about execution'
Boston Scientific CFO Jeffrey Capello tells MassDevice.com how the medical device company plans to pull itself out of one of the roughest patches in its history. MassDevice.com sat down with Boston...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for February 13, 2013
If you read nothing else today, make sure you're still in the know with MassDevice +3.Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of...
View ArticleClik here to view.
A "new era" for Boston Scientific?
Boston Scientific officials are bullish that the company will grow sales by the end of the year, ending more than 2 year of sliding revenues.Boston Scientific (NYSE:BSX) expects positive sales growth...
View ArticleClik here to view.
Parkinson's patients could use neurostim earlier, researchers say
Researchers reported that patients with Parkinson's disease benefited significantly from receiving neurostimulation implants earlier that is currently recommended.Patients with Parkinson's disease may...
View ArticleClik here to view.
FDA approves 1st "bionic eye" for the blind
U.S. health regulators showed some love to Second Sight Medical, granting FDA approval to the company's market-1st "bionic eye" system for patients with blindness due to a rare disease.California...
View ArticleClik here to view.
Cardinal Health to drop $2B on AssuraMed
Cardinal Health says it's agreed to pony up more than $2 billion for medical supplies provider AssuraMed, itself fresh off the M&A trail.Cardinal Health (NYSE:CAH) said it plans to spend $2.07...
View Article
